Recent advances in radiosensitivity determinants in melanoma.
Auteurs : Krayem M, Ghanem GE, Van Gestel D Jaar : 2022 Journal : Curr Opin Oncol
Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma.
Auteurs : Najem A, Soumoy L, Sabbah M, Krayem M, Awada A, Journe F, Ghanem GE Jaar : 2022 Journal : Cells
The Road to Dissemination: The Concept of Oligometastases and the Barriers for Widespread Disease.
Auteurs : AlGhamdi H, Dhont J, Krayem M, De Bruyn P, Engels B, Van Gestel D, Van den Begin R Jaar : 2022 Journal : Cancers (Basel)
Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance.
Auteurs : Kehagias P, Kindt N, Krayem M, Najem A, Agostini G, Acedo Reina E, Bregni G, Sclafani F, Journe F, Awada A, Ghanem GE, Hendlisz A Jaar : 2022 Journal : Cells
Corrigendum to 'p53 Reactivation by PRIMA-1Met (APR-246) sensitises V600E/KBRAF melanoma to vemurafenib'[Eur J of Cancer 55 (2016) 98-110].
Auteurs : Krayem M, Journe F, Wiedig M, Morandini R, Najem A, Salès F, Van Kempen LC, Sibille C, Awada A, Marine JC, Ghanem G Jaar : 2022 Journal : Eur J Cancer